Propanc Biopharma, Valuation
| PPCB Stock | USD 0.19 0.01 5.00% |
Propanc Biopharma, seems to be fairly valued based on Macroaxis valuation methodology. Our model determines the value of Propanc Biopharma Common from analyzing the company fundamentals such as EBITDA of (2.14 M), return on asset of -13.07, and Shares Owned By Insiders of 1.60 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Propanc Biopharma,'s price fluctuation is out of control at this time. Calculation of the real value of Propanc Biopharma Common is based on 3 months time horizon. Increasing Propanc Biopharma,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Propanc Biopharma, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Propanc Pink Sheet. However, Propanc Biopharma,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.19 | Real 0.18 | Hype 0.19 |
The real value of Propanc Pink Sheet, also known as its intrinsic value, is the underlying worth of Propanc Biopharma Common Company, which is reflected in its stock price. It is based on Propanc Biopharma,'s financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Propanc Biopharma,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Propanc Biopharma Common helps investors to forecast how Propanc pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Propanc Biopharma, more accurately as focusing exclusively on Propanc Biopharma,'s fundamentals will not take into account other important factors: About Propanc Biopharma, Valuation
The pink sheet valuation mechanism determines Propanc Biopharma,'s current worth on a weekly basis. Our valuation model uses a comparative analysis of Propanc Biopharma,. We calculate exposure to Propanc Biopharma,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Propanc Biopharma,'s related companies.Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia. Propanc Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
8 Steps to conduct Propanc Biopharma,'s Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Propanc Biopharma,'s potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Propanc Biopharma,'s valuation analysis, follow these 8 steps:- Gather financial information: Obtain Propanc Biopharma,'s financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Propanc Biopharma,'s revenue streams: Identify Propanc Biopharma,'s primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Propanc Biopharma,'s industry and market trends, including the size of the market, growth rate, and competition.
- Establish Propanc Biopharma,'s growth potential: Evaluate Propanc Biopharma,'s management, business model, and growth potential.
- Determine Propanc Biopharma,'s financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Propanc Biopharma,'s estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Propanc Biopharma, Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 220.4 M | |
| Retained Earnings | -61.6 M |
Complementary Tools for Propanc Pink Sheet analysis
When running Propanc Biopharma,'s price analysis, check to measure Propanc Biopharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Propanc Biopharma, is operating at the current time. Most of Propanc Biopharma,'s value examination focuses on studying past and present price action to predict the probability of Propanc Biopharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Propanc Biopharma,'s price. Additionally, you may evaluate how the addition of Propanc Biopharma, to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |